Sustained Impact of Intermittently Scanned Continuous Glucose Monitoring on Treatment Satisfaction and Severe Hypoglycemia in Adults with Type 1 Diabetes (FUTURE): An Analysis in People with Normal and Impaired Awareness of Hypoglycemia
- 1 April 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in Diabetes Technology & Therapeutics
- Vol. 25 (4), 231-241
- https://doi.org/10.1089/dia.2022.0452
Abstract
Objective: Nationwide reimbursement of intermittently-scanned continuous glucose monitoring (isCGM) was introduced in Belgium (2016). This real-world observational study investigates the impact of isCGM over 24 months on adults with type 1 diabetes with impaired or normal awareness of hypoglycemia (IAH or NAH). Methods: We included 1905 people who started first-generation 14-day FreeStyle Libre (without alerts). Sixteen percent had IAH. Primary endpoint was evolution of quality of life (QOL); secondary endpoints were evolution of severe hypoglycemia, work absenteeism, HbA1c, and sensor-measured outcomes. Results: At baseline, people with IAH (n=308) had significantly worse QOL than people with NAH (n=1594). Only people with IAH improved on the hypoglycemia fear survey-worry subscale after 24 months (22.8 [95%CI 21.4-24.2] baseline; 20.6 [19.0-22.1] 24 months, p=0.002). For both groups, Diabetes Treatment Satisfaction Scale improved over 24 months (IAH: +3.1 [2.1-4.1],p<0.001; NAH: +2.3 [1.9-2.7], p<0.001), while general QOL, diabetes distress, and HbA1c remained stable. People with IAH showed the strongest decline in work absenteeism and severe hypoglycemia (36.4% having an event six months prior to isCGM-initiation; 16.0% having an event during last six months of follow-up, p<0.001), with similar observations for hypoglycemia hospitalization, and hypoglycemia coma. Over 24 months, people with IAH spent more time in hypoglycemia, but less time in hyperglycemia than people with NAH. Conclusion: This data show sustained improvement of severe hypoglycemia, work absenteeism and hypoglycemia fear after isCGM-reimbursement, mostly driven by people with IAH. Together with improved treatment satisfaction, irrespective of hypoglycemia awareness level, isCGM without alerts is a valuable tool under long-term real-world conditions.Keywords
This publication has 41 references indexed in Scilit:
- Patient experience of hypoglycaemia unawareness in Type 1 diabetes: are patients appropriately concerned?Diabetic Medicine, 2011
- Psychometric Properties of the Hypoglycemia Fear Survey-II for Adults With Type 1 DiabetesDiabetes Care, 2011
- Hypoglycemia Unawareness Is Associated With Reduced Adherence to Therapeutic Decisions in Patients With Type 1 DiabetesDiabetes Care, 2009
- Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetesDiabetic Medicine, 2008
- How hypoglycaemia can affect the life of a person with diabetesDiabetes/Metabolism Research and Reviews, 2008
- A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient educationPatient Education and Counseling, 2007
- Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetesCurrent Medical Research and Opinion, 2005
- Methods to Explain the Clinical Significance of Health Status MeasuresMayo Clinic Proceedings, 2002
- Reduced Awareness of Hypoglycemia in Adults With IDDM: A prospective study of hypoglycemic frequency and associated symptomsDiabetes Care, 1995
- Frequency of Severe Hypoglycemia in Patients With Type I Diabetes With Impaired Awareness of HypoglycemiaDiabetes Care, 1994